首页> 外文期刊>Internal medicine. >Successful Allogeneic Hematopoietic Stem Cell Transplantation in a Young Patient with Richter Syndrome Presenting with Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma with Different Cell Origins
【24h】

Successful Allogeneic Hematopoietic Stem Cell Transplantation in a Young Patient with Richter Syndrome Presenting with Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma with Different Cell Origins

机译:在患有慢性淋巴细胞白血病和不同细胞起源的弥漫性大B细胞淋巴瘤的Richter综合征的年轻患者中成功进行异基因造血干细胞移植

获取原文
           

摘要

A 32-year-old woman was referred to our hospital due to systemic lymphadenopathy. The patient's peripheral blood showed expansion of CD5+CD20+CD38+CD23- mature lymphocytes. However, the axillary lymph nodes were infiltrated by both CD23+ large lymphocytes and CD23- small lymphocytes. Because the pattern of the rearranged immunoglobulin heavy chain gene was different between the peripheral blood and lymph node samples in a Southern blot analysis, the patient was diagnosed with Richter syndrome, in which diffuse large B-cell lymphoma develops from a clone distinct from B-cell chronic lymphocytic leukemia. After undergoing rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) therapy, the patient was successfully treated with allogeneic hematopoietic transplantation, and no relapse was observed for three years.
机译:一名32岁妇女因全身淋巴结肿大被转诊到我们医院。患者的外周血显示出CD5 + CD20 + CD38 + CD23 -成熟淋巴细胞的扩增。然而,腋窝淋巴结被CD23 + 大淋巴细胞和CD23 -小淋巴细胞浸润。由于在Southern印迹分析中外周血和淋巴结样本中免疫球蛋白重链基因重排的模式不同,因此该患者被诊断为Richter综合征,其中弥漫性大B细胞淋巴瘤由不同于B-细胞慢性淋巴细胞性白血病。接受利妥昔单抗,环磷酰胺,阿霉素,长春新碱和泼尼松龙(R-CHOP)治疗后,该患者成功接受异基因造血移植治疗,三年未见复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号